Needle in the Haystack? Screening Large Populations for HCM
08/11/22 • 30 min
It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Listen to this podcast to gain insight into hypertrophic cardiomyopathy (HCM) screening and what it means to your patients.
It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Listen to this podcast to gain insight into hypertrophic cardiomyopathy (HCM) screening and what it means to your patients.
Previous Episode
HCM and New Pharmacological Agents
Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes. In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/hypertrophic-cardiomyopathy-podcast-series-518753/needle-in-the-haystack-screening-large-populations-for-hcm-67692429"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to needle in the haystack? screening large populations for hcm on goodpods" style="width: 225px" /> </a>
Copy